Cargando…

Development and validation of nomograms for predicting survival outcomes in patients with T1-2N1 breast cancer to identify those who could not benefit from postmastectomy radiotherapy

PURPOSE: In this study, we aimed to develop and validate nomograms for predicting the survival outcomes in patients with T1-2N1 breast cancer to identify the patients who could not benefit from postmastectomy radiotherapy (PMRT). METHODS: Data from 10191 patients with T1-2N1 breast cancer were extra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pu, Hongyu, Luo, Yunbo, Zhang, Linxing, Li, Xin, Li, Fangwei, Chen, Jingtai, Qian, Shuangqiang, Tang, Yunhui, Zhao, Xiaobo, Hou, Lingmi, Gao, Yanchun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086367/ https://www.ncbi.nlm.nih.gov/pubmed/37056328 http://dx.doi.org/10.3389/fonc.2023.1112687

Ejemplares similares

Single progesterone receptor-positive phenotype has the similar clinicopathological features and outcome as triple-negative subtype in metastatic breast cancer
por: Luo, Yunbo, et al.
Publicado: (2023)

Correlation Analysis of Breast and Thyroid Nodules: A Cross-Sectional Study
por: Chen, Jingtai, et al.
Publicado: (2021)

Automated treatment planning of postmastectomy radiotherapy
por: Kisling, Kelly, et al.
Publicado: (2019)

Risk-Adapted Postmastectomy Radiotherapy Decision Based on Prognostic Nomogram for pT1-2N1M0 Breast Cancer: A Multicenter Study
por: Li, Ming, et al.
Publicado: (2020)

Application of thermoplastic elastomer (TPE) bolus in postmastectomy radiotherapy
por: Gong, Pan, et al.
Publicado: (2022)

The survival benefit of postmastectomy radiotherapy for breast cancer patients with T1-2N1 disease according to molecular subtype
por: Wei, Jinli, et al.
Publicado: (2020)

A prospective feasibility study of a 1-mm bolus for postmastectomy radiotherapy
por: Kawamoto, Terufumi, et al.
Publicado: (2021)

Post-mastectomy Radiotherapy in T1-2 Breast Cancer Patients With One to Three Lymph Node Metastases: A Propensity Score Matching Analysis
por: Chen, Maoshan, et al.
Publicado: (2020)

Role of postmastectomy radiotherapy in early-stage (T1–2N0–1M0) triple-negative breast cancer: a systematic review
por: Chen, Fengxia, et al.
Publicado: (2017)

Effect of postmastectomy radiotherapy on T1-2N1M0 triple-negative breast cancer
por: Xia, Lin-Yu, et al.
Publicado: (2022)

Effect of postmastectomy radiotherapy on pT(1-2)N(1) breast cancer patients with different molecular subtypes()
por: Guo, Xin-Yuan, et al.
Publicado: (2021)

Dosimetric assessment of brass mesh bolus for postmastectomy photon radiotherapy
por: Manger, Ryan, et al.
Publicado: (2016)

Real-world impact of postmastectomy radiotherapy in T1–2 breast cancer with one to three positive lymph nodes
por: Li, Feng-Yan, et al.
Publicado: (2020)

Comparison of Treatment Outcome between Hypofractionated Radiotherapy and Conventional Radiotherapy in Postmastectomy Breast Cancer
por: Tovanabutra, Chokaew, et al.
Publicado: (2020)

Postmastectomy Radiotherapy for Locally Advanced Breast Cancer Receiving Neoadjuvant Chemotherapy
por: Meattini, Icro, et al.
Publicado: (2014)

Clinical decision making in postmastectomy radiotherapy in node negative breast cancer
por: Barrientos, Rodrigo, et al.
Publicado: (2018)

The effect of postmastectomy radiotherapy in node-positive triple-negative breast cancer
por: Zhang, Lei, et al.
Publicado: (2020)

Which Patients Might Benefit from Postmastectomy Radiotherapy in Breast Cancer Patients with T1-2 Tumor and 1-3 Axillary Lymph Nodes Metastasis?
por: Kong, Moonkyoo, et al.
Publicado: (2013)

Dosimetric Comparison of Postmastectomy Radiotherapy Plans for Synchronous Bilateral Breast Cancer, Including Regional Lymph Node Irradiation
por: Wu, Xiuxiu, et al.
Publicado: (2023)

Effect of tumor-infiltrating lymphocytes depending on the presence of postmastectomy radiotherapy on the prognosis in pT1-2N1M0 breast cancer
por: Zhang, Lina, et al.
Publicado: (2023)

Artificial Intelligence-Based Automated Treatment Planning of Postmastectomy Volumetric Modulated Arc Radiotherapy
por: Jiang, Shengpeng, et al.
Publicado: (2022)

Do Recent Advances in Diagnostic and Therapeutic Procedures Negate the Benefit of Postmastectomy Radiotherapy in N1 Patients With a Low Risk of Locoregional Recurrence?
por: Chang, Jee Suk, et al.
Publicado: (2015)

Non-compliance with a postmastectomy radiotherapy guideline: Decision tree and cause analysis
por: Razavi, Amir R, et al.
Publicado: (2008)

Prepectoral Implant-Based Breast Reconstruction and Postmastectomy Radiotherapy: Short-Term Outcomes
por: Sigalove, Steven, et al.
Publicado: (2017)

A Comparative Study of Hypofractionated and Conventional Radiotherapy in Postmastectomy Breast Cancer Patients
por: Rastogi, Kartick, et al.
Publicado: (2018)

Dosimetric and Radiobiological Comparison of Five Techniques for Postmastectomy Radiotherapy with Simultaneous Integrated Boost
por: Tang, Du, et al.
Publicado: (2020)

Dosimetric evaluation of photons versus protons in postmastectomy planning for ultrahypofractionated breast radiotherapy
por: Oonsiri, Puntiwa, et al.
Publicado: (2022)

Practical Model to Optimize the Strategy of Adjuvant Postmastectomy Radiotherapy in T1-2N1 Breast Cancer With Modern Systemic Therapy
por: Xu, Fei-Fei, et al.
Publicado: (2022)

A Prognostic Risk Stratification Model to Identify Potential Population Benefiting From Postmastectomy Radiotherapy in T1–2 Breast Cancer With 1–3 Positive Axillary Lymph Nodes
por: Hou, Niuniu, et al.
Publicado: (2021)

Impact of postmastectomy radiation therapy in T1-2 breast cancer patients with 1-3 positive axillary lymph nodes
por: Yin, Hang, et al.
Publicado: (2017)

Predictive Value of Molecular Subtyping for Locoregional Recurrence in Early-Stage Breast Cancer with N1 without Postmastectomy Radiotherapy
por: Wen, Ge, et al.
Publicado: (2016)

Surface Dose Measurements in Chest Wall Postmastectomy Radiotherapy to Achieve Optimal Dose Delivery with 6 MV Photon Beam
por: Lobo, Dilson, et al.
Publicado: (2021)

No difference in dose distribution in organs at risk in postmastectomy radiotherapy with or without breast implant reconstruction
por: Liljegren, Annelie, et al.
Publicado: (2014)

Two-Stage Prosthetic Breast Reconstruction after Mastectomy with or without Prior Postmastectomy Radiotherapy
por: Lam, Thomas C., et al.
Publicado: (2017)

Conventional Versus Different Hypofractionated Radiotherapy Dosage Schedules in Postmastectomy Advanced Breast Cancer
por: Jain, Neeraj, et al.
Publicado: (2022)

Comparison of long-term results between radiotherapy after breast-conserving surgery and postmastectomy radiotherapy in stage T1-2N1M0 breast cancer
por: Lan, Xiao-Wen, et al.
Publicado: (2019)

Postmastectomy Radiotherapy Improves Disease-Free Survival of High Risk of Locoregional Recurrence Breast Cancer Patients with T1-2 and 1 to 3 Positive Nodes
por: He, Zhen-Yu, et al.
Publicado: (2015)

Comparing hypofractionated to conventional fractionated radiotherapy in postmastectomy breast cancer: a meta-analysis and systematic review
por: Liu, Lei, et al.
Publicado: (2020)

Robustness of VMAT to setup errors in postmastectomy radiotherapy of left-sided breast cancer: Impact of bolus thickness
por: He, Yipeng, et al.
Publicado: (2023)

Effectiveness of intraoperative radiotherapy vs hypofractionated postmastectomy radiotherapy for early stage breast cancer: A protocol for systematic review and meta-analysis
por: Feng, Jiang-Yi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mdtp4gp50a9aeuc5gf7feksq94